Initial HIV Therapy for Adults and Treatment-Associated Weight Gain

A randomized clinical trial in treatment-naive adults with HIV compared a regimen of doravirine, lamivudine, and tenofovir disoproxil fumarate against a regimen of dolutegravir, emtricitabine, and tenofovir alafenamide for effects on weight gain and viral suppression. The current material is a summary-level description and does not report specific weight change or virologic suppression results.